"The Johns Hopkins Kimmel Cancer Center’s Medical Oncology practice at Green Spring Station in Lutherville, Maryland,is located on the first floor of Pavilion III, the practice features programs in breast cancer, lymphoma, lung cancer, melanoma, ovarian cancer, gastrointestinal cancers and genitourinary cancers. With private exam rooms, modern infusion bays, imaging, pharmacy and lab services, the practice is designed to provide an optimal cancer care patient experience."

During the past decade, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Medivation, Inc." with 1 trials as a collaborator and "Myriad Genetic Laboratories, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins" are "Melanoma" (3 trials), "Advanced Breast Cancer (Female)" (1 trials), "Advanced Cancer" (1 trials), "Advanced Melanoma" (1 trials) and "BRCA 1 Gene Mutation" (1 trials). Many other conditions were trialed in "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins" in a lesser frequency.

Most popular intervention types in "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins" are "Drug" (10 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nivolumab" (5 trials), "Ipilimumab" (4 trials), "Palbociclib" (2 trials), "Placebo" (2 trials) and "Avelumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins" are 7 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 4 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".